SEOUL, Oct. 7 (Korea Bizwire) — South Korea’s pharmaceutical and biotech firms are racing to close out the year under mounting pressure, with looming U.S. tariffs and sluggish drug development emerging as key challenges after the Chuseok holiday. Industry sources said Monday that the most immediate concern is the “U.S. tariff risk” following President Donald [...]
SEOUL, Sept. 22 (Korea Bizwire) — A string of hacking incidents at South Korea’s telecommunications and financial companies has prompted pharmaceutical and biotech firms to tighten their defenses, wary that breaches involving sensitive clinical data and intellectual property could trigger irreparable damage. Industry officials said this week that companies are moving quickly to reinforce security policies [...]
SEOUL, May 5 (Korea Bizwire) — As global competition heats up in the pharmaceutical and biotech sectors, major players in South Korea and abroad are accelerating efforts to expand the therapeutic indications of existing drugs—a strategy aimed at maximizing product value and securing wider market share. According to industry sources on May 4, Korea Novo Nordisk [...]